Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development of convenient crystallization inhibition assays for structure-activity relationship studies in the discovery of crystallization inhibitors

Medicinal Chemistry Research(2023)10.1007/s00044-023-03061-7Source: DataRank Database

Development of convenient crystallization inhibition assays for structure-activity relationship studies in the discovery of crystallization inhibitors is a research paper published in Medicinal Chemistry Research (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.81)OA: greenTopics (21)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Haifa Albanyan,Yiling Wang ORCID,Yanhui Yang ORCID,Amrik Sahota ORCID,Longqin Hu ORCID

Live enrichment

PubMed:37681210 OpenAlex:https://openalex.org/W4366758004

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: R01DK112782

FWCI

0.81

Citation Percentile

0.7%

Citation Trend

2024

2026

greenLicense: https://www.springernature.com/gp/researchers/text-and-data-mining

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10482073/pdf/nihms-1903585.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s00044-023-03061-7.pdf

publisherhttps://link.springer.com/article/10.1007/s00044-023-03061-7/fulltext.html

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10482073

Fields of Study

Kidney Stones and Urolithiasis TreatmentsBiomedical Research and PathophysiologyPorphyrin Metabolism and Disorders

Keywords

CrystallizationChemistryCystineCombinatorial chemistryCentrifugationCystinuriaDrug discoveryChromatographySupersaturationBiochemistryCysteineOrganic chemistryEnzymeCrystallization inhibition assayCrystallization inhibitorsKidney stone diseaseL-CystineUrolithiasis

Sustainable Development Goals

SDG 0: Good health and well-being